Teva Presents Strategic Plan to Deliver Strong Growth

During its investor meeting on January 7, Teva Pharmaceutical Industries Ltd. presented an updated strategy, highlighting key opportunities for growth and announcing its long-term goals of reaching revenues of $31 billion and non-GAAP net income of $6.8 billion, or 22% of revenues, by 2015.
Finchannel